The prognostic value of 18F-PSMA-1007 PET/CT in predicting pathological upgrading of newly diagnosed prostate cancer from systematic biopsy to radical prostatectomy
ObjectiveThis study aimed to evaluate predictors for upgrading of newly diagnosed prostate cancer from systematic biopsy (SB) to radical prostatectomy (RP) using fluorine-18 prostate-specific membrane antigen 1007 (18F-PSMA-1007) positron emission tomography/computed tomography (PET/CT) and associat...
Main Authors: | Anqi Zheng, Zhuonan Wang, Liang Luo, Ruxi Chang, Jungang Gao, Bo Wang, Xiaoyi Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1169189/full |
Similar Items
-
Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer
by: Zhuonan Wang, et al.
Published: (2022-11-01) -
The 18F-PSMA-1007 PET/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer
by: Zhuonan Wang, et al.
Published: (2022-08-01) -
18F-PSMA-1007 PET/CT Performance on Risk Stratification Discrimination and Distant Metastases Prediction in Newly Diagnosed Prostate Cancer
by: Zhuonan Wang, et al.
Published: (2021-10-01) -
The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
by: Jun-jie Hong, et al.
Published: (2020-11-01) -
Automated [18F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination
by: Sadahiro Naka, et al.
Published: (2020-07-01)